Compagnie des Alpes // 2021 Universal Registration Document

6 SHARE CAPITAL AND SHAREHOLDING Share capital

6.1 Share capital At 30 September 2021, the share capital of Compagnie des Alpes amounted to €25,182,041 and consisted of 50,364,082 fully paid-up shares with a nominal value of €0.50, in registered or bearer form, as chosen by the shareholder. These shares account for 100% of the capital and voting rights outstanding.

There are no outstanding founder’s shares, no income-sharing certificates, no convertible or exchangeable bonds, no voting rights certificates or investment certificates. There are also no double voting rights or priority shares.

6.1.1 CHANGE IN THE AMOUNT OF THE COMPANY’S SHARE CAPITAL OVER THE LAST THREE YEARS

capital) (the “Contribution”). On 5 July 2021, the Board of Directors of Compagnie des Alpes authorised the conclusion of a definitive contribution agreement and said agreement was signed by Compagnie des Alpes and CDC on 6 July 2021. On 16 September 2021, the Extraordinary Shareholders’ Meeting of Compagnie des Alpes approved the Contribution and its terms and conditions, noted the definitive fulfilment of all the conditions precedent to the Contribution ( i.e. (i) CDC obtaining from the AMF a decision to waive the obligation to file a draft takeover offer for Compagnie des Alpes shares, purged of any appeal procedures or, where applicable, of any appeal, (ii) the approval by the Extraordinary Shareholders’ Meeting of Compagnie des Alpes of the terms of the Contribution, (iii) the remission by the contribution auditors appointed by order of the President of the Paris Commercial Court dated 15 March 2021 of their reports on the value of the Contribution and on the fairness of the remuneration of the Contribution and (iv) the waiver by the société anonyme d Économie Mixte Locale “SEML Patrimoniale de la Vienne”, another shareholder of SPF, to its pre-emptive right as part of the Contribution project) as well as the resulting capital increase. In accordance with the provisions of the French Accounting Standards Authority (“ANC”) regulation no. 2014-03 of 5 June 2014, as updated by ANC regulation no. 2020- 05 of 24 July 2020, the SPF shares were contributed at their actual value, i.e. the total amount of twenty million euros (€20 million), in consideration for the issue by Compagnie des Alpes in favour of CDC of one million two hundred and thirty-seven thousand one hundred and eighty (1,237,180) new ordinary shares with a nominal value of fifty euro cents (€0.50) each, to be created by a capital increase of a total nominal amount of six hundred and eighteen thousand five hundred and ninety euros (€618,590). The value of the Contribution and the exchange ratio were determined on the basis of standard multi-criteria valuation methods. The share capital of Compagnie des Alpes was thus increased to twenty-five million one hundred and eighty-two thousand and forty-one euros (€25,182,041) and is composed of fifty million three hundred and sixty-four thousand and eighty-two (50,364,082) shares with a nominal value of fifty euro cents (€0.50).

In a decision dated 26 April 2021, the Chairman and Chief Executive Officer recognised the capital increase following the conclusion of bonus share allocation plan no. 22 through the creation of 53,350 new shares. In addition, the Shareholders’ Meeting of 25 March 2021 authorised the Board of Directors to carry out a capital reduction not motivated by losses by reducing the nominal value of the shares and allocating the amount of the capital reduction to the “Issue premiums” account. The Board of Directors meeting of 28 April 2021, in view of the certificate stating that there were no objections from the creditors issued by the registry of the Commercial Court of Paris, noted the completion of the reduction in the share capital of Compagnie des Alpes. Following this transaction, the share capital of Compagnie des Alpes amounted to €12,281,725.50 divided into 24,563,451 shares with no nominal value. The Shareholders’ Meeting of 25 March 2021 also authorised the Board of Directors to carry out a capital increase with preferential subscription rights for shareholders (capped at a nominal amount of €300 million). On 31 May 2021, the Board of Directors, acting under the delegation of authority granted by the Shareholders’ Meeting, decided on the principle of a capital increase and sub delegated all powers to its Chief Executive Officer to carry it out under certain conditions. On 8 June 2021, using the powers delegated to him, the Chief Executive Officer decided to carry out a capital increase with preferential subscription rights for a total nominal amount of €12,281,725.50, per issue of 24,563,451 new shares with a nominal value of €0.50 each, at a price of €9.40 each (including an issue premium of €8.90). On 28 June 2021, the Chief Executive Officer noted that the capital increase of €230,896,439.40 (issue premium included) through the issue of 24,563,451 new shares had been fully subscribed and that the share capital was now at €24,563,451. Lastly, on 31 May 2021, Compagnie des Alpes and CDC signed a memorandum of understanding relating to the proposed contribution by CDC to Compagnie des Alpes of 371,402 shares in Parc du Futuroscope (“SPF”) (representing approximately 24% of its share

216

Compagnie des Alpes I 2021 Universal registration document